D.E. BioMedical | Advanced Medical Technology & Devices: Partnerships

The partnership with the following firms and the governmental Office of the Chief Scientist (OCS), included, mainly, support in:

Management

Marketing

Market research

Business development

Medical management and consultation

Distribution

Representation

The support was given, both, in the fields of pharmaceutical and medical devices.

Taro Pharmaceutical Industries Ltd.
Taro International (Public, OTC:TAROF) sells active pharmaceutical ingredients and finished dosage form products in many countries around the world.

Taro’s prescription and over-the-counter medications are used primarily in dermatology, cardiology, pediatrics and neurology.

Syneron Medical Ltd.
Syneron Medical Ltd. (NASDAQ: ELOS) manufactures and distributes medical aesthetic devices that are powered by its proprietary, patented ELOS combined-energy technology of bi-polar Radio Frequency (RF) and optical energy (either laser or light).

ELOS (Electro-optical Synergy) technology enables enhanced safety and effectiveness in treating a wide range of medical-aesthetic conditions. Founded in 2000, the corporate headquarters for Syneron Medical Ltd. is located in Israel. Syneron has offices and distributors throughout the world including North American Headquarters in Canada, North American Logistics Center in Irvine, California, European Headquarters in Germany, and Asia-Pacific Headquarters in Hong Kong which provide sales, service and support.

Office of the Chief Scientist (OTC)
Israeli Ministry of Industry, trade and Labor, The State of Israel.
The role of the OCS is to assist in the development of new technologies as a mean of fostering the economy, encouraging technological entrepreneurship, leveraging science- skilled resources' supporting high added value R&D, enhancing the knowledge of advanced industries and promoting cooperation in R&D both nationally and internationally.